Richard Lim
InvestorPartner at Cure Ventures · Board director at Alessa Therapeutics · Chief Executive Officer at Xenimmune
Boston, Massachusetts
Writes $100K – $5M checks · typically $1.5M
Find your path to Richard
673 people in our graph share verified history with Richard — schools, employers, funds. One of them is your warm intro.
Adam ValkinunlockedRichard: together at Harvard University (1992–1993)
×7Richard: together at Harvard Business School
×4Richard: together at Harvard University
About
Managing Partner with three decades in life sciences spanning corporate development and venture investing. Previously Managing Member and President of Omega Funds and founded MVM Life Science Partners' US operations.
Contact· self-published, not guessed
Board director at Alessa Therapeutics
Intro paths
→
In turn, Richard can intro founders to Alessa Therapeutics's investors below.
Alessa Therapeutics's investors · 4
Co-founders at Alessa Therapeutics
PM
Pamela MunsterFounder, Director & Chief Scientific Advisor
Chief Executive Officer at Xenimmune
Intro paths
→
In turn, Richard can intro founders to Xenimmune's investors below.
Xenimmune's investors · 1
Experience
- Cure VenturesManaging Partner and Co-Foundercurrent2021 — presentBoston, MA
- Undisclosed Clinical Stage BiopharmaCBO and SVP2020 — 2021Boston, MA
- Omega FundsManaging Director2008 — 2020
- MVM PartnersGeneral Partner2002 — 2008
- Saunders Karp & MegrueVice President2000 — 2002
- L.E.K. ConsultingManager1993 — 2000
Skills & more
Venture CapitalPrivate EquityMergers & AcquisitionsDue DiligenceStart-upsCorporate DevelopmentGrowth CapitalEntrepreneurshipInvestor RelationsInvestment BankingCorporate FinanceFinancial Modeling
+12 more
LBODeal SourcingBusiness StrategyPrivate PlacementsM&A experienceManagement ConsultingCapital RaisingBiotechnologyStrategyStrategic PlanningLife SciencesValuationFrom Richard's professional profile.
Investments
Led
Investor
Per curated public sources.
Colleagues at Cure Ventures
Albert J. Robichaud
Partner at Cure Ventures
Annie Mitsak
Partner at Cure Ventures
Bill Amsbaugh
CTO and Partner at Cure Ventures
Courtney Turner
Director of Finance at Cure Ventures
David Fallace
Managing Partner at Cure Ventures
Dr. Michael Aberman
Investor at Cure Ventures
Dr. Milenko Cicmil
Investor at Cure Ventures
Drew King
CFO and Partner at Cure Ventures
Frequently asked questions
- Who is Richard Lim?
- Managing Partner with three decades in life sciences spanning corporate development and venture investing. Previously Managing Member and President of Omega Funds and founded MVM Life Science Partners' US operations.
- Where does Richard Lim work?
- Richard Lim is Partner at Cure Ventures and Board director at Alessa Therapeutics and Chief Executive Officer at Xenimmune.
- What check size does Richard Lim write?
- Richard Lim typically writes checks of $100K – $5M.
- What companies has Richard Lim invested in?
- Investments tracked here include Gossamer Bio, Nuvation Bio.
- Where did Richard Lim go to school?
- Richard Lim studied at Harvard University; Harvard Business School; Phillips Exeter Academy.
- Does Richard Lim lead rounds?
- Yes — Richard Lim has led 1 tracked investment.
Same school
Also attended Harvard University2,000
Ron ConwayFounder of SV AngelAlfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalG
+ 1,994 more
Also attended Harvard Business School2,000
Aileen LeeFounder & Managing Partner of Cowboy VenturesJim BreyerFounder & CEO of Breyer CapitalMike Maples JrCo-founding Partner at FloodgateNeeraj AgrawalGeneral Partner at Battery VenturesHristo BorisovCo-founder & CEO of PayhawkVictoria TreygerGeneral Partner at Felicis Ventures
+ 1,994 more
Also attended Phillips Exeter Academy155
Nathaniel HardingManaging Partner at Cortado VenturesMichael GreeleyCo-Founder and General Partner at Flare Capital PartnersChris SaxmanDigital health entrepreneur, startup mentor, skier, fly fisherman, Steelers fanatic, Co-head of Health 2.0 Denver/Boulder ChapterMax Von PoelnitzPartner at Foothill VenturesJohn H. N. FisherFounder and Managing Partner at DFJJacques PouheManaging Director at Skyview Ventures
+ 149 more
Shared employers
Also worked at Omega Funds20
Nessan BerminghamInvestor at Khosla VenturesLiam FlahertyInvestor at Silversmith Capital PartnersAnnie MitsakPartner at Cure VenturesJohn MaraganoreAdvisor at Oak HC/FTWalter StockingerManaging Partner at Hadean VenturesPål R. JensenSenior Advisor Operations at Hadean Ventures
+ 14 more
Also worked at MVM Partners11
Alex PasteurPartner at F-Prime Capital PartnersBali MuralidharGlobal Head of Life Sciences & CIO at AbingworthHugo HarrodPartner at MVM Life Science PartnersNeil AkhurstCOO at MVM Life Science PartnersKevin ChengPartner at MVM Life Science PartnersKyle DempseyPartner at MVM Life Science Partners
+ 5 more
Also worked at L.E.K. Consulting194
Chris BischoffInvestment Team at General CatalystMattias LjungmanInvestor at Moonfire VenturesJessica SchultzPartner at NorthzoneFrancois PrinslooInvestor at MedicxiMiranda GuerreroExecutive Assistant at Sapphire VenturesStacey HeroInvestor at Third Rock Ventures
+ 188 more